The DOI matches its Crossref record; 476 of the 476 references it cites were found in a registry or an index.
Schizophrenia, “Just the Facts”: What we know in 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Logic of Scientific Discovery.
Hutchison, T. W., & Popper, K. R. (1959) · Economica · doi:10.2307/2550489 · Cited by 7,499
(1996) · Cited by 6,884
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
Gottesman, I. I., & Gould, T. D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.636 · Cited by 5,615
Dementia Praecox or the Group of Schizophrenias
(1951) · Journal of the American Medical Association · doi:10.1001/jama.1951.02920270079043 · Cited by 4,407
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Cited by
Uncovering the roles of rare variants in common disease through whole-genome sequencing
Cirulli, E. T., & Goldstein, D. B. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2779 · Cited by 1,136
Schizophrenia, “just the facts” 4. Clinical features and conceptualization
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.005 · Cited by 1,027
Self-citationTorous, J., Kiang, M. V., Lorme, J., & Onnela, J.-P. (2016) · JMIR Mental Health · doi:10.2196/mental.5165 · Cited by 758
“…consequences of relapse in schizophrenia include decreased quality of life, with relationships and employment often in jeopardy [43], as well as likely neurotoxic effects [44], cognitive decline [45], and often a return to an overall lower level of baseline functioning than prior to relapse [46].”
BackgroundSchizophrenia, “Just the Facts” What we know in 2008. 2. Epidemiology and etiology
TANDON, R., KESHAVAN, M., & NASRALLAH, H. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.04.011 · Cited by 720
Self-citationKirkbride, J. B., Errazuriz, A., Croudace, T. J., Morgan, C., Jackson, D., Boydell, J., Murray, R. M., & Jones, P. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031660 · Cited by 537
Advances in multimodal data fusion in neuroimaging: Overview, challenges, and novel orientation
Zhang, Y.-D., Dong, Z., Wang, S.-H., Yu, X., Yao, X., Zhou, Q., Hu, H., Li, M., Jiménez-Mesa, C., Ramirez, J., et al. (2020) · Information Fusion · doi:10.1016/j.inffus.2020.07.006 · Cited by 453
Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.025 · Cited by 385
Self-citationSchizophrenia, “just the facts”: What we know in 2008Part 3: Neurobiology
KESHAVAN, M., TANDON, R., BOUTROS, N., & NASRALLAH, H. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.020 · Cited by 347
Self-citationLinscott, R. J., & van Os, J. (2010) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.032408.153506 · Cited by 324
“There are several recent high-quality reviews of the epidemiology of schizophrenia (e.g., McGrath et al. 2008, Messias et al. 2007, Saha et al. 2005, Tandon et al. 2008).”
BackgroundMethodGenetic Relationships Between Schizophrenia, Bipolar Disorder, and Schizoaffective Disorder
Cardno, A. G., & Owen, M. J. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu016 · Cited by 286
Hippocampal Volume Reduction in First-Episode and Chronic Schizophrenia: A Review and Meta-Analysis
Adriano, F., Caltagirone, C., & Spalletta, G. (2012) · The Neuroscientist · doi:10.1177/1073858410395147 · Cited by 285
Sex/gender differences in the brain and cognition in schizophrenia
Mendrek, A., & Mancini-Marïe, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.10.013 · Cited by 266
A systematic review of the antipsychotic properties of cannabidiol in humans
Iseger, T. A., & Bossong, M. G. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.033 · Cited by 261
Endophenotypes in schizophrenia: A selective review
Allen, A. J., Griss, M. E., Folley, B. S., Hawkins, K. A., & Pearlson, G. D. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.01.016 · Cited by 210
“…endophenotypes, but concentrates mainly on SCZ and REL, with little data on HC. Recent articles, such as the “Just the Facts” series in this journal (Tandon et al., 2008 a, b; Keshavan et al. 2008), have brought to light the importance of evaluating endophenotypes for schizophrenia in order to…”
BackgroundDiverse types of genetic variation converge on functional gene networks involved in schizophrenia
Gilman, S. R., Chang, J., Xu, B., Bawa, T. S., Gogos, J. A., Karayiorgou, M., & Vitkup, D. (2012) · Nature Neuroscience · doi:10.1038/nn.3261 · Cited by 200
Cancer mortality in patients with schizophrenia: An 11‐year prospective cohort study
Tran, E., Rouillon, F., Loze, J., Casadebaig, F., Philippe, A., Vitry, F., & Limosin, F. (2009) · Cancer · doi:10.1002/cncr.24383 · Cited by 173
Disability and schizophrenia: a systematic review of experienced psychosocial difficulties
Świtaj, P., Anczewska, M., Chrostek, A., Sabariego, C., Cieza, A., Bickenbach, J., & Chatterji, S. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-193 · Cited by 170
“Although several long-term follow-up studies have undermined the original view about its inevitably poor outcome and proved that varying degrees of recovery are possible [2], schizophrenia is still ranked among the top ten leading causes of diseaserelated disability in the world [3] and is consistently demonstrated to…”
BackgroundDigital Technology Use Among Individuals with Schizophrenia: Results of an Online Survey
Gay, K., Torous, J., Joseph, A., Pandya, A., & Duckworth, K. (2016) · JMIR Mental Health · doi:10.2196/mental.5379 · Cited by 161
Ayhan, Y., Abazyan, B., Nomura, J., Kim, R., Ladenheim, B., Krasnova, I. N., Sawa, A., Margolis, R. L., Cadet, J. L., Mori, S., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2009.144 · Cited by 148
Vancampfort, D., Probst, M., Helvik Skjaerven, L., Catalán-Matamoros, D., Lundvik-Gyllensten, A., Gómez-Conesa, A., Ijntema, R., & De Hert, M. (2012) · Physical Therapy · doi:10.2522/ptj.20110218 · Cited by 141
Effects of single dose intranasal oxytocin on social cognition in schizophrenia
Davis, M. C., Lee, J., Horan, W. P., Clarke, A. D., McGee, M. R., Green, M. F., & Marder, S. R. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.04.023 · Cited by 124
Schizophrenia patients with a history of childhood trauma have a pro-inflammatory phenotype
Dennison, U., McKernan, D., Cryan, J., & Dinan, T. (2012) · Psychological Medicine · doi:10.1017/s0033291712000074 · Cited by 114
Immune system gene dysregulation in autism and schizophrenia
Michel, M., Schmidt, M. J., & Mirnics, K. (2012) · Developmental Neurobiology · doi:10.1002/dneu.22044 · Cited by 107
“Twin studies have provided estimates of heritability in ASD and SCZ as high as 90 and 80%, respectively, suggesting that genetic differences play a pivotal role in the etiology of both disorders (Tandon et al., 2008; Geschwind, 2009).”
Liu, C. H., Keshavan, M. S., Tronick, E., & Seidman, L. J. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv047 · Cited by 104
Self-citationGenetic contributions to behavioural diversity at the gene-environment interface
Bendesky, A., & Bargmann, C. I. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3065 · Cited by 103
A Population Genetic Approach to Mapping Neurological Disorder Genes Using Deep Resequencing
Myers, R. A., Casals, F., Gauthier, J., Hamdan, F. F., Keebler, J., Boyko, A. R., Bustamante, C. D., Piton, A. M., Spiegelman, D., Henrion, E., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001318 · Cited by 97
Bordeleau, M., Carrier, M., Luheshi, G. N., & Tremblay, M.-È. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.06.001 · Cited by 75
Cognitive and neural models of threat appraisal in psychosis: a theoretical integration
Underwood, R., Kumari, V., & Peters, E. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.03.016 · Cited by 51
“Bearing in mind the extensive evidence demonstrating that cognitive de fi cits are associated with psychotic disorder (Tandon et al., 2008), differences in appraisals between those with and without a ‘ need for care ’ may simply re fl ect differing levels of cognitive impairment.”
Perona‐Garcelán, S., García‐Montes, J. M., Ductor‐Recuerda, M. J., Vallina‐Fernández, O., Cuevas‐Yust, C., Pérez‐Álvarez, M., Salas‐Azcona, R., & Gómez‐Gómez, M. T. (2012) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.2011.02015.x · Cited by 50
Thomas, N., Shawyer, F., Castle, D. J., Copolov, D., Hayes, S. C., & Farhall, J. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-198 · Cited by 35
“Finally, we considered that cognitive impairments commonly seen in schizophrenia [51-53] could interfere in understanding abstract metaphors and retaining information in the ACT condition, thereby moderating outcomes.”
BackgroundStress, Schizophrenia, and Violence: A Machine Learning Approach
Kirchebner, J., Sonnweber, M., Nater, U. M., Günther, M., & Lau, S. (2022) · Journal of Interpersonal Violence · doi:10.1177/0886260520913641 · Cited by 34
“SSD is still one of the leading causes of disease-related disability in the world (Świtaj et al., 2012; Tandon et al., 2008) and is associated with many serious stressors that would also contribute to criminal offending in people without mental disorders, but especially mentally ill people are at…”
BackgroundPredictors of disability: A 5-year cohort study of first-episode schizophrenia
Johnson, S., Sathyaseelan, M., Charles, H., & Jacob, K. S. (2014) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2014.01.003 · Cited by 24
Jauhar, S., Krishnadas, R., Nour, M. M., Cunningham-Owens, D., Johnstone, E. C., & Lawrie, S. M. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.06.070 · Cited by 23
Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia
Kılıç, N., Tasci, G., Yılmaz, S., Öner, P., & Korkmaz, S. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13020276 · Cited by 15
“In addition, psychiatric diseases and neurological diseases have been detected with artificial intelligence in the literature [1].”
BackgroundPolymorphism of TPH2 gene rs120074175 is not associated with risk factors of schizophrenia
Barliana, M., Laksono, J., Sumirtanurdin, R., Dania, H., Ramadhani, F., Perwitasari, D., & Abdulah, R. (2019) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_216_19 · Cited by 3
“Although schizophrenia has a prevalence of only 1% in the entire population of the world,[2] this disease is included among the 10 diseases that cause disability.[3] People who are affected by schizophrenia tend to have a shorter age compared to the general population, which is due to the high possibility to develop o…”
Background
Metadata
- Authors
- Tandon, R., Keshavan, M. S., & Nasrallah, H. A.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2008-03
- Volume
- 100
- Issue
- 1-3
- Pages
- 4-19
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2132485329
- Cited by
- 409
- References
- 476
- FWCI
- 24.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.